Orgenesis (ORGS) Stock Chart & Stock Price History $1.00 -0.01 (-0.99%) As of 07/23/2025 12:54 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Orgenesis Stock Price Performance The Orgenesis (ORGS) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 47.09%. In the past month, the stock has decreased 42.86%, reflecting recent market activity. As of the latest close, Orgenesis traded at $1.00 with a market cap of $4.80 million and volume of 200 shares. Receive ORGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.85%1 Month Performance-42.86%3 Month Performance-55.95%Year-To-Date Performance-47.09% ORGS Stock Chart for Thursday, July, 24, 2025 ORGS Chart by TradingView Orgenesis Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$1.00$1.00$1.00$0.25200 shs$4.80 million07/23/2025$1.01$1.00-0.99%$1.00$0.25200 shs$4.80 million07/22/2025$1.01$1.01$1.08$0.0011,698 shs$4.85 million07/21/2025$1.04$1.01-2.88%$1.08$0.0011,698 shs$4.85 million07/18/2025$1.11$1.04-6.31%$1.04$1.04456 shs$4.99 million07/17/2025$1.12$1.11-0.89%$1.12$1.112,420 shs$5.33 million07/16/2025$1.19$1.12-5.88%$1.17$1.1011,980 shs$5.38 million07/15/2025$1.18$1.19+0.85%$1.21$1.134,844 shs$5.71 million07/14/2025$1.07$1.18+10.28%$1.30$1.007,381 shs$5.66 million07/11/2025$1.30$1.07-17.69%$1.30$1.0516,314 shs$5.14 million Get the Latest News and Ratings for ORGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$1.32$1.30-1.81%$1.36$1.2213,828 shs$6.24 million07/09/2025$1.41$1.32-6.17%$1.41$1.322,408 shs$6.35 million07/08/2025$1.51$1.41-6.56%$1.41$1.311,502 shs$6.77 million07/07/2025$1.33$1.51+13.53%$1.51$1.353,151 shs$7.25 million07/04/2025$1.33$1.33$1.49$1.2812,038 shs$6.38 million07/03/2025$1.53$1.33-13.07%$1.49$1.2812,038 shs$7.34 million07/02/2025$1.53$1.53$1.58$1.53668 shs$7.34 million07/01/2025$1.48$1.53+3.73%$1.54$1.445,455 shs$7.34 million06/30/2025$1.50$1.48-1.67%$1.49$1.355,697 shs$7.08 million06/27/2025$1.67$1.50-10.18%$1.60$1.455,541 shs$7.20 million06/26/2025$1.66$1.67+0.60%$1.79$1.676,489 shs$8.01 million06/25/2025$1.75$1.66-5.14%$1.72$1.4221,124 shs$7.97 million06/24/2025$1.74$1.75+0.34%$1.79$1.693,538 shs$8.40 million06/23/2025$1.80$1.74-3.11%$1.77$1.611,209 shs$8.37 million Related Companies JATT Acquisition Stock Price Chart Elevation Oncology Stock Price Chart Chemomab Therapeutics Stock Price Chart Longeveron Stock Price Chart Calidi Biotherapeutics Stock Price Chart Natural Alternatives International Stock Price Chart Relmada Therapeutics Stock Price Chart Reviva Pharmaceuticals Stock Price Chart Finch Therapeutics Group Stock Price Chart VYNE Therapeutics Stock Price Chart Receive ORGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORGS) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orgenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ORGS Stock Alerts